compare tirzepatide vs semaglutide for weight loss In adults with obesity but not diabetes, leads to significantly greater than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Tirzepatide Vs Semaglutide – 2026

References for the retatrutide data: Jastreboff et al., NEJM 2023: Sanyal et al., Nature Medicine 2024: Giblin et al., TRIUMPH rationale, Diabetes Obesity Metabolism 2025: How to Minimize Side Effects and Maximize Comfort GLP-1s can cause nausea, constipation, and appetite suppression

Increased levels of glycated hemoglobin a1c and iron deficiency anemia: A review

PlexusDx supports ongoing optimization through personalized protocols and the option to explore tirzepatide (dual GLP-1/GIP therapy) if needed, both priced affordably with no tier-based price increases

Frequently asked questions Timelines vary

Do You Lose More Muscle on Semaglutide or Tirzepatide

USA 106 , 77687773 (2009)